Evi-1 as a critical regulator of leukemic cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-06-15
著者
-
KUROKAWA Mineo
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
GOYAMA Susumu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Goyama Susumu
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Goyama Susumu
Univ. Cincinnati Coll. Medicine Oh Usa
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine The University Of Tokyo
関連論文
- A new three-way variant t(15;22;17)(q22;q11.2;q21) in acute promyelocytic leukemia
- Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-β signaling
- Essential roles of VLA-4 in the hematopoietic system
- Evi-1 as a critical regulator of leukemic cells
- T cell acute lymphoblastic leukemia arising from familial platelet disorder
- Ischemic Colitis as a Manifestation of Thrombotic Microangiopathy Following Bone Marrow Transplantation
- A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
- Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma
- Acute eosinophilic pneumonia is a non-infectious lung complication after allogeneic hematopoietic stem cell transplantation
- Molecular and cytogenetic response of chronic myelogenous leukemia treated with imatinib mesylate : one institutional experience in Japan
- Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
- Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma : a case report and literature review
- ESHAP therapy effective in a patient with Langerhans cell sarcoma
- Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation
- A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy
- Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells
- AML1/Runx1 as a Versatile Regulator of Hematopoiesis : Regulation of Its Function and a Role in Adult Hematopoiesis
- IgG-associated immune thrombocytopenia in Waldenstrom macroglobulinemia
- Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients
- High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis
- Interstitial pneumonia associated with progression of myelodysplastic syndrome
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFRα fusion gene
- Splenic Peliosis in a Patient with Aplastic Anemia during Danazol Therapy
- Human invariant natural killer T cells : implications for immunotherapy
- Blimp-1 is a tumor suppressor gene in lymphoid malignancies
- Role of AML1/Runx1 in the pathogenesis of hematological malignancies
- Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies
- Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
- A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period
- CD30-positive anaplastic variant diffuse large B cell lymphoma : a rare case presented with cutaneous involvement
- Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia
- Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin
- Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl
- The effect of iron overload and chelation on erythroid differentiation
- Pure red cell aplasia with follicular lymphoma showing regression and progression parallel to lymphoma
- Pituitary lymphoma developing within pituitary adenoma
- A Comparative Analysis of Meropenem and Doripenem in Febrile Patients with Hematologic Malignancies: a Single-Center Retrospective Study
- Follicular lymphoma presenting with massive splenomegaly
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Efficacy of pleural biopsy for diagnosis of pleural effusion due to chronic GVHD after hematopoietic stem cell transplantation